Japan stopped using the MMR vaccine seven years ago - virtually the only developed nation to turn its back on the jab. Government health chiefs claim a four-year experiment with it has had serious ...

MSD and Moderna’s individualised cancer vaccine mRNA-4157 has shown impressive efficacy in a phase 2b trial in skin cancer melanoma, leaving the partners speculating about a possible regulatory ...